Guangdong Kanghua Healthcare Co., Ltd. (3689.HK)
HKD 2.16
(-1.37%)
HKD 2.16
(-1.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 308.56 Million CNY | 34.97% |
| 2022 | 233.79 Million CNY | -23.04% |
| 2021 | 298.46 Million CNY | 139.54% |
| 2020 | 138.79 Million CNY | -48.93% |
| 2019 | 257.33 Million CNY | -12.37% |
| 2018 | 269.74 Million CNY | -0.62% |
| 2017 | 253.48 Million CNY | 9.47% |
| 2016 | 229.13 Million CNY | -3.79% |
| 2015 | 193.28 Million CNY | 2.29% |
| 2014 | 179.52 Million CNY | 14.24% |
| 2013 | 153.19 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 28.24 Million CNY | -56.27% |
| 2024 Q2 | 28.24 Million CNY | 0.0% |
| 2023 Q2 | 48.99 Million CNY | 0.0% |
| 2023 Q3 | 64.59 Million CNY | 31.84% |
| 2023 Q4 | 64.59 Million CNY | 0.0% |
| 2023 Q1 | 48.99 Million CNY | -15.25% |
| 2023 FY | - CNY | 34.97% |
| 2022 FY | - CNY | -23.04% |
| 2022 Q4 | 57.81 Million CNY | 0.0% |
| 2022 Q3 | 57.81 Million CNY | 325.11% |
| 2022 Q2 | 13.6 Million CNY | 0.0% |
| 2022 Q1 | 13.6 Million CNY | -82.6% |
| 2021 Q3 | 78.16 Million CNY | 87.68% |
| 2021 Q2 | 41.64 Million CNY | 0.0% |
| 2021 Q1 | 41.64 Million CNY | -41.5% |
| 2021 FY | - CNY | 139.54% |
| 2021 Q4 | 78.16 Million CNY | 0.0% |
| 2020 FY | - CNY | -48.93% |
| 2020 Q1 | 2.05 Million CNY | -96.85% |
| 2020 Q4 | 71.18 Million CNY | 0.0% |
| 2020 Q3 | 71.18 Million CNY | 3356.54% |
| 2020 Q2 | 2.05 Million CNY | 0.0% |
| 2019 Q1 | 58.52 Million CNY | -5.93% |
| 2019 Q4 | 65.34 Million CNY | 0.0% |
| 2019 FY | - CNY | -12.37% |
| 2019 Q2 | 58.52 Million CNY | 0.0% |
| 2019 Q3 | 65.34 Million CNY | 11.65% |
| 2018 Q3 | 62.21 Million CNY | 6.32% |
| 2018 FY | - CNY | -0.62% |
| 2018 Q4 | 62.21 Million CNY | 0.0% |
| 2018 Q2 | 58.51 Million CNY | 0.0% |
| 2018 Q1 | 58.51 Million CNY | -9.25% |
| 2017 Q2 | 62.26 Million CNY | 0.0% |
| 2017 Q4 | 64.47 Million CNY | 0.0% |
| 2017 Q3 | 64.47 Million CNY | 3.56% |
| 2017 Q1 | 62.26 Million CNY | 1.46% |
| 2017 FY | - CNY | 9.47% |
| 2016 Q2 | 53.2 Million CNY | 0.0% |
| 2016 Q3 | 61.36 Million CNY | 15.35% |
| 2016 Q4 | 61.36 Million CNY | 0.0% |
| 2016 FY | - CNY | -3.79% |
| 2016 Q1 | 53.2 Million CNY | -12.42% |
| 2015 FY | - CNY | 2.29% |
| 2015 Q2 | 63.7 Million CNY | 0.0% |
| 2015 Q3 | 63.7 Million CNY | 0.0% |
| 2015 Q4 | 60.74 Million CNY | -4.64% |
| 2015 Q1 | 63.7 Million CNY | 0.0% |
| 2014 Q1 | 61.05 Million CNY | 0.0% |
| 2014 Q2 | 61.05 Million CNY | 0.0% |
| 2014 Q3 | 61.05 Million CNY | 0.0% |
| 2014 Q4 | 63.7 Million CNY | 4.33% |
| 2014 FY | - CNY | 14.24% |
| 2013 Q4 | 61.05 Million CNY | 12.52% |
| 2013 Q3 | 54.26 Million CNY | 0.0% |
| 2013 Q2 | 54.26 Million CNY | 0.0% |
| 2013 Q1 | 54.26 Million CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 Q4 | 54.26 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -348.18% |
| UMP Healthcare Holdings Limited | 161.98 Million HKD | -90.492% |
| Human Health Holdings Limited | 104.06 Million HKD | -196.513% |
| EuroEyes International Eye Clinic Limited | 292.1 Million HKD | -5.635% |
| Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | -130.941% |
| Bamboos Health Care Holdings Limited | 52.75 Million HKD | -484.865% |
| Beijing Health (Holdings) Limited | -44.19 Million HKD | 798.249% |
| C-MER Eye Care Holdings Limited | 359.88 Million HKD | 14.26% |
| Town Health International Medical Group Limited | 53.5 Million HKD | -476.743% |
| Medicskin Holdings Limited | 6.77 Million HKD | -4453.763% |
| Hang Chi Holdings Limited | 81.58 Million HKD | -278.201% |